Background In patients with a first eradication failure, a second (rescue) therapy still fails in>
20% of cases. Aim To compare rifabutin and levofloxacin rescue regimens in patients with …

Background In some cases, H elicobacter pylori infection persists even after three
eradication treatments. Aim To evaluate the efficacy of an empirical fourth‐line rescue …

Background/Aims There is increasing need for third-line therapy of Helicobacter pylori due
to increasing level of antibiotics resistance. The aim of this study was to compare rifabutin …

abstract Aim. Eradication therapy with proton pump inhibitor, clarithromycin and amoxicillin
is extensively used, although it fails in a considerable number of cases. A 'rescue'therapy …

Background Current 'rescue'therapies provide inadequate Helicobacter pylori eradication
rates because of antibiotic resistance. Aim To test the efficacy of a modified triple regimen …

Aliment Pharmacol Ther 2012; 35: 209–221 Summary Background Even with the current
most effective treatment regimens, a relevant proportion of patients will fail to eradicate …

Background: The ideal treatment for patients who have failed eradication of Helicobacter
pylori infection after standard proton pump inhibitor‐based triple therapies has still to be …

AIM Eradication therapy with proton pump inhibitor, clarithromycin and amoxicillin fails in a
considerable number of cases. A rescue therapy still fails in more than 20% of the cases …

Even with the currently most effective treatment regimens, about 10–20% of patients will fail
to obtain eradication of Helicobacter pylori infection. Therefore, in designing a treatment …

Helicobacter pylori (H pylori) infection is the main cause of gastritis, gastroduodenal ulcer
disease, and gastric cancer. After more than 20 years of experience in H pylori treatment, in …